Bloomberg the Company & Products

Bloomberg Anywhere Login


Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.


Financial Products

Enterprise Products


Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000


Industry Products

Media Services

Follow Us

Last 1,853 INR
Change Today 0.00 / 0.00%
Volume 0.0
DIVI On Other Exchanges
Natl India
As of 7:05 AM 05/22/15 All times are local (Market data is delayed by at least 15 minutes).

divi's laboratories ltd (DIVI) Snapshot

Previous Close
Day High
Day Low
52 Week High
04/8/15 - 1,969
52 Week Low
05/26/14 - 1,210
Market Cap
Average Volume 10 Days
Shares Outstanding
Dividend Yield
Current Stock Chart for DIVI'S LABORATORIES LTD (DIVI)

Related News

No related news articles were found.

divi's laboratories ltd (DIVI) Related Businessweek News

No Related Businessweek News Found

divi's laboratories ltd (DIVI) Details

Divi’s Laboratories Limited manufactures and sells active pharmaceutical ingredients (API) and intermediates for generics in India. The company also offers building blocks for peptides and nucleotides; carotenoids, such as apocarotenal, betacarotene, lycopene, astaxanthin, canthaxanthin, etc.; nutraceuticals; protected amino acids comprising BOC, FMOC, and CBZ; and novel ligands, including binol, binap, and others. The company also offers custom synthesis of API and advanced intermediates for discovery compounds to pharma companies. It also exports its products primarily to European and the American countries. The company was formerly known as Divi’s Research Center and changed its name to Divi’s Laboratories Limited in 1994. Divi’s Laboratories Limited was founded in 1990 and is headquartered in Hyderabad, India.

Founded in 1990

divi's laboratories ltd (DIVI) Top Compensated Officers

Chairman, Managing Director and Member of Cor...
Total Annual Compensation: 9.0M
President of Operations, Director of Operatio...
Total Annual Compensation: 7.8M
Executive Director and Member of Corporate So...
Total Annual Compensation: 8.4M
Director of Projects, Executive Director and ...
Total Annual Compensation: 7.8M
Compensation as of Fiscal Year 2014.

divi's laboratories ltd (DIVI) Key Developments

Divi's Laboratories Limited Announces Standalone Earnings Results for the Third Quarter and Nine Months Ended December 31, 2014

Divi's Laboratories Limited announced standalone earnings results for the third quarter and nine months ended December 31, 2014. The company has earned a profit after tax of INR 22.1 billion on a total income of INR 79.1 billion, on a stand-alone basis, for the quarter ended December 31, 2014. For the corresponding quarter of the last year the company earned a PAT of INR 21.9 billion on a total income of INR 68.9 billion. For the nine-month period ended December 31, 2014, the company earned a total income of INR 226.7 billion as compared to INR 177.3 billion during the corresponding nine-month period of last year. PBT for the current nine-month period came to INR 78.5 billion as against a PBT of INR 76.4 billion for the previous period. PAT for the current nine-months is INR 61.8 billion as against INR 59.9 billion for the previous period.

Divi's Laboratories Limited, Board Meeting, Jan 31, 2015

Divi's Laboratories Limited, Board Meeting, Jan 31, 2015. Agenda: To consider the un-audited financial results for the third quarter and nine months ended December 31, 2014.

Divi's Laboratories Limited to Report Q3, 2015 Results on Jan 31, 2015

Divi's Laboratories Limited announced that they will report Q3, 2015 results on Jan 31, 2015


Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
DIVI:IN 1,852.95 INR +11.60

DIVI Competitors

Market data is delayed at least 15 minutes.

Company Last Change
Biocon Ltd 447.05 INR 0.00
Dishman Pharmaceuticals & Chemicals Ltd 157.50 INR 0.00
Piramal Enterprises Ltd 988.30 INR 0.00
Shasun Pharmaceuticals Ltd 367.30 INR 0.00
Torrent Pharmaceuticals Ltd 1,239 INR 0.00
View Industry Companies

Industry Analysis


Industry Average

Valuation DIVI Industry Range
Price/Earnings 30.1x
Price/Sales 9.2x
Price/Book 7.9x
Price/Cash Flow 26.9x
TEV/Sales 9.0x

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact DIVI'S LABORATORIES LTD, please visit Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at